Firefly Neuroscience (AIFF) Net Income towards Common Stockholders (2010 - 2026)

Firefly Neuroscience's Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 87.92% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$9.3 million (up 59.44% YoY), while the FY2025 annual figure was -$24.5 million, down 134.52% from the prior year.
• Net Income towards Common Stockholders was -$2.1 million for Q1 2026 at Firefly Neuroscience, up from -$2.7 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $100615.0 in Q1 2023 to a low of -$17.3 million in Q1 2025.
• Historically, Net Income towards Common Stockholders has averaged -$3.8 million across 5 years, with a median of -$2.1 million in 2026.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders plunged 4820.62% in 2022, then jumped 104.84% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$8.4 million in 2022, then surged by 101.2% to $100615.0 in 2023, then sank by 4362.78% to -$4.3 million in 2024, then surged by 36.61% to -$2.7 million in 2025, then rose by 22.99% to -$2.1 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$2.1 million (Q1 2026), -$2.7 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.